Diff Profiles › MTBLS3056_0001_00000001

Sham_vs_UIR

Sham vs UIR

p-value ≤ 0.05 27 significant 2025-09-26 00:00:00 Study: MTBLS3056
80 Total Features
27 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS3056_0001_00000001
Linked study
MTBLS3056 — Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
Comparison
Sham vs UIR
Group A
Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.
Group B
Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows for the assessment of the effects of UIR on kidney function and structure.
Total features tested
80
Significant features
27
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
HXACOUQIXZGNBF-UHFFFAOYSA-N 4-pyridoxinecarboxylic acid up 8.205 2.05e-08
SRNWOUGRCWSEMX-TYASJMOZSA-N ribose adenosinediphosphate up 16.62 9.07e-06
UGQMRVRMYYASKQ-KQYNXXCUSA-N hypoxanthine <small>D</small>-riboside up 9.919 1.8e-06
WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-Cinnamic acid up 73.07 0.00118
HEBKCHPVOIAQTA-QWWZWVQMSA-N D-Arabinitol up 8.645 1.61e-06
VWWQXMAJTJZDQX-UYBVJOGSSA-N FAD up 7.124 3.95e-06
XNRNNGPBEPRNAR-JQBLCGNGSA-N TXB2 down 0.08178 0.000212
FVTCRASFADXXNN-SCRDCRAPSA-N riboflavin 5'-(dihydrogen phosphate) up 4.649 3.27e-05
FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-Ribulose 5-phosphate up 3.363 4.42e-06
CBQJSKKFNMDLON-JTQLQIEISA-N Acetylphenylalanine up 4.034 5.31e-05